Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
734 studies found for:    osteoporosis AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb
Condition: Osteoporosis With Current Fragility Fracture
Intervention: Behavioral: Osteoporosis prevention program
2 Recruiting Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
Condition: Post Menopausal Osteoporosis
Intervention: Drug: AMG 162 - Prolia
3 Completed A Study of the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
4 Completed Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
5 Completed Post-menopausal Women Osteoporosis(Phase III)
Condition: Postmenopausal Women Osteoporosis
Interventions: Drug: risedronate combine;   Drug: Risedronate;   Drug: Placebo(for Risedronate);   Drug: Placebo(for risedronate combine)
6 Completed Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: teriparatide
7 Active, not recruiting Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Alendronate
8 Completed TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: placebo;   Drug: ALX1-11
9 Unknown  Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
Condition: Osteoporosis
Intervention: Other: Questionnaires about compliance and persistence with bisphosphonates treatment
10 Active, not recruiting Oklahoma Native American Women's Osteoporosis Screening Study
Condition: Osteoporosis
Intervention:
11 Completed STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)
Condition: Postmenopausal Women With Primary Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH)
12 Completed
Has Results
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
Condition: Osteoporosis
Interventions: Drug: Full Length Parathyroid Hormone, PTH(1-84);   Drug: Strontium Ranelate
13 Completed The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis
Condition: Osteoporosis
Intervention: Behavioral: Education
14 Recruiting Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Condition: Adult Idiopathic Generalized Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Saline Placebo
15 Recruiting Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
16 Completed Optimal Management of Women With Wrist Fractures
Conditions: Osteoporosis;   Osteopenia
Intervention: Procedure: Educational Material and Reminder
17 Completed
Has Results
Foot Orthoses and Elderly Women With Osteoporosis
Condition: Osteoporosis
Intervention: Device: Foot orthosis (Orthotics Unit of the Clinical Hospital of UNICAMP)
18 Completed Safety and Efficacy of Whole-body Vibration as add-on Treatment of Osteoporosis in Post-menopausal Women
Condition: Osteoporosis in Post-menopausal Women
Intervention: Device: Whole body vibration
19 Active, not recruiting Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Conditions: Menopause;   Fracture;   Osteoporosis
Intervention: Drug: Teriparatide (PTH 1-34)
20 Completed Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Test group;   Drug: Reference group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.